36个品种拟进院，独家品种占比超35%

赛柏蓝2025-12-06

编者按：本文来自米内网，作者苍穹；赛柏蓝转载，编辑晓琳近日，西藏自治区医院发布公告称，拟引进36款新药以满足临床用药需求。其中，独家品种（含剂型独家，下同）占比超35%，包括地达西尼胶囊、递法明片等2025H1在中国公立医疗机构终端销售额增速均达两位数及以上的潜力品种；12款国采品种在列，仅集采中选企业允许申报。此次拟进院新药包含27款化药、5款中成药和4款生物药；按治疗大类统计，神经系统药物、...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2589382961?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-12-06 19:21","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2589382961","market":"hk","top_or_hot":-1,"title":"36个品种拟进院，独家品种占比超35%","media":"赛柏蓝","content":"<div>\n<p>编者按：本文来自米内网，作者苍穹；赛柏蓝转载，编辑晓琳近日，西藏自治区医院发布公告称，拟引进36款新药以满足临床用药需求。其中，独家品种（含剂型独家，下同）占比超35%，包括地达西尼胶囊、递法明片等2025H1在中国公立医疗机构终端销售额增速均达两位数及以上的潜力品种；12款国采品种在列，仅集采中选企业允许申报。此次拟进院新药包含27款化药、5款中成药和4款生物药；按治疗大类统计，神经系统药物、...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251206192444a7278966&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>36个品种拟进院，独家品种占比超35%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n36个品种拟进院，独家品种占比超35%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-12-06 19:21 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251206192444a7278966&s=b><strong>赛柏蓝</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>编者按：本文来自米内网，作者苍穹；赛柏蓝转载，编辑晓琳近日，西藏自治区医院发布公告称，拟引进36款新药以满足临床用药需求。其中，独家品种（含剂型独家，下同）占比超35%，包括地达西尼胶囊、递法明片等2025H1在中国公立医疗机构终端销售额增速均达两位数及以上的潜力品种；12款国采品种在列，仅集采中选企业允许申报。此次拟进院新药包含27款化药、5款中成药和4款生物药；按治疗大类统计，神经系统药物、...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251206192444a7278966&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02348","symbol_name":"东瑞制药","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251206192444a7278966&s=b","article_id":"2589382961","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251206192444a7278966&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2589382961","pubTimestamp":1765020078,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"36款拟引进的新药中，独家品种占比超35%，涉及复方鳖甲软肝片、地达西尼胶囊、递法明片等潜力品种；另有12个国采品种在列，石药集团、华海药业、倍特药业等集采中选企业优势十足。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"02348":"东瑞制药","01093":"石药集团","BK1191":"制药","06887":"东阳光药"},"translate_title":"36 varieties are planned to enter the hospital, and exclusive varieties account for more than 35%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02348":0.9,"06887":0.9,"01093":0.9},"content_text":"编者按：本文来自米内网，作者苍穹；赛柏蓝转载，编辑晓琳近日，西藏自治区医院发布公告称，拟引进36款新药以满足临床用药需求。其中，独家品种（含剂型独家，下同）占比超35%，包括地达西尼胶囊、递法明片等2025H1在中国公立医疗机构终端销售额增速均达两位数及以上的潜力品种；12款国采品种在列，仅集采中选企业允许申报。此次拟进院新药包含27款化药、5款中成药和4款生物药；按治疗大类统计，神经系统药物、心脑血管系统药物为主力军，占据5个及以上席位；从医保分类上看，医保甲类药、医保乙类药和非医保药各有4个、21个和11个。36款拟引进的新药中，独家品种占比超35%，涉及复方鳖甲软肝片、地达西尼胶囊、递法明片等潜力品种；另有12个国采品种在列，石药集团、华海药业、倍特药业等集采中选企业优势十足。拟遴选进院新药注：带*为独家品种，标红为国采品种复方鳖甲软肝片为内蒙古福瑞医疗的独家中成药，功能主治软坚散结、化瘀解毒、益气养血，用于慢性乙型肝炎肝纤维化、早期肝硬化属瘀血阻络、气血亏虚兼热毒未尽证等，目前已纳入国家医保乙类药目录。在中国城市公立医院、县级公立医院、城市社区中心以及乡镇卫生院（简称中国公立医疗机构）终端，复方鳖甲软肝片2022-2024年销售额均保持同比正增长；2025H1收获近1.2亿元，是肝病中成药TOP10产品。近年来中国公立医疗机构终端复方鳖甲软肝片销售趋势（单位：万元）此外，12款国采品种拟纳入进院采购目录。其中，丙戊酸钠注射用浓溶液集采中选企业包括青峰医药、倍特药业、汇宇制药等；氯沙坦钾氢氯噻嗪片集采中选企业包括华海药业、浙江诺得药业、东瑞制药等；瑞戈非尼片集采中选企业包括齐鲁制药、南京正大天晴制药、创诺医药等；磷酸奥司他韦胶囊集采中选企业包括华海药业、东阳光药、石药集团等；注射用醋酸卡泊芬净集采中选企业包括正大天晴药业、一品红制药、海思科等。中国公立医疗机构终端部分市场份额实现正增长的国采中选企业根据此次药品遴选进院的公告要求，国采品种仅允许集采中选企业申报，意味着上述集采中选企业有望借助本轮进院机会，进一步扩大其产品市场份额。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2589382961","isCrawlerRequest":true}